Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

2 treatments under study, led by Dapagliflozin

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Completed1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (1)

Showing 1 of 1 trials
NCT05884866Phase 2Completed

A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.

Showing all 1 trials

Research Network

Common Treatments

  • Dapagliflozin1
  • Balcinrenone1

Active Sponsors

  • Klinikum Nuernberg1
  • Klinikum Nürnberg1
  • Winicker-Norimed Medizinische Forschung GmbH1

Top Investigators

Related Conditions

  • Electrolyte And Fluid Balance Conditions1
  • Chronic Renal Failure1
  • Stage 3 Chronic Kidney Disease1
  • Chronic Kidney Disease Stage 31

Activity Timeline